Brief: Avadel Pharmaceuticals Announces Publication in Clinical Therapeutics of Data Highlighting Weight Loss in People with Narcolepsy Treated with LUMRYZ
20/08/2024 13:24
Aug 20 (Reuters) - Avadel Pharmaceuticals PLC AVDL.O :
* AVADEL PHARMACEUTICALS ANNOUNCES PUBLICATION IN CLINICAL
THERAPEUTICS OF DATA HIGHLIGHTING WEIGHT LOSS IN PEOPLE WITH
NARCOLEPSY TREATED WITH LUMRYZ™ (SODIUM OXYBATE)
EXTENDED-RELEASE ORAL SUSPENSION
Source text for Eikon: ID:nGNX2MPmLp
Further company coverage: AVDL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Avadel Pharmaceuticals
See all newsBrief: Alkermes PLC Completes Acquisition Of Avadel Pharmaceuticals PLC, Accelerating Entry Into Sleep Medicine Market
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 08:10 AM
H Lundbeck steps down from takeover for Avadel, shares rise 3%
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Viking, Valvoline, Alphabet